Article info

PDF

Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options

Authors

  • Preena Tanna UCL Institute of Ophthalmology, University College London, London, UK Moorfields Eye Hospital, London, UK PubMed articlesGoogle scholar articles
  • Rupert W Strauss UCL Institute of Ophthalmology, University College London, London, UK Moorfields Eye Hospital, London, UK Departments of Ophthalmology, Medical University Graz and Johannes Kepler University, Linz, Austria PubMed articlesGoogle scholar articles
  • Kaoru Fujinami UCL Institute of Ophthalmology, University College London, London, UK Moorfields Eye Hospital, London, UK National Institute of Sensory Organs, National Hospital Organization, Tokyo Medical Centre, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Michel Michaelides UCL Institute of Ophthalmology, University College London, London, UK Moorfields Eye Hospital, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Michel Michaelides, UCL Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, UK; michel.michaelides{at}ucl.ac.uk
View Full Text

Citation

Tanna P, Strauss RW, Fujinami K, et al
Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options

Publication history

  • Received 4 April 2016
  • Revised 20 June 2016
  • Accepted 11 July 2016
  • Published in print 1 January 2017.
  • Published online 14 December 2016.
  • Published first 4 August 2016.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.